argenx SE (ARGNF)
OTCMKTS · Delayed Price · Currency is USD
619.44
0.00 (0.00%)
At close: Aug 14, 2025
argenx SE Market Cap
argenx SE has a market cap or net worth of $40.95 billion as of August 19, 2025. Its market cap has increased by 34.23% in one year.
Market Cap
40.95B
Enterprise Value
37.09B
Revenue
3.12B
Ranking
n/a
PE Ratio
31.98
Stock Price
$619.44
Market Cap Chart
Since July 10, 2014, argenx SE's market cap has increased from 166.50M to 40.95B, an increase of 24,492.64%. That is a compound annual growth rate of 64.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2025 | 40.95B | 9.20% |
| Dec 31, 2024 | 37.50B | 67.18% |
| Dec 29, 2023 | 22.43B | 8.92% |
| Dec 30, 2022 | 20.59B | 11.15% |
| Dec 31, 2021 | 18.53B | 32.86% |
| Dec 31, 2020 | 13.95B | 102.37% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 781.22M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 580.94M |
| Glass House Brands | 567.91M |
| American Oncology Network | 379.23M |
| Northwest Biotherapeutics | 363.17M |
| CytoDyn | 344.75M |